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Abstract
Objectives To apply the Delphi exercise with iterative involvement of radiologists and pulmonologists with the aim of 
defining a structured reporting template for high-resolution computed tomography (HRCT) of patients with fibrosing lung 
disease (FLD).
Methods The writing committee selected the HRCT criteria—the Delphi items—for rating from both radiology panelists 
(RP) and pulmonology panelists (PP). The Delphi items were first rated by RPs as “essential”, “optional”, or “not relevant”. 
The items rated “essential” by < 80% of the RP were selected for the PP rating. The format of reporting was rated by both 
RP and PP.
Results A total of 42 RPs and 12 PPs participated to the survey. In both Delphi round 1 and 2, 10/27 (37.7%) items were 
rated “essential” by more than 80% of RP. The remaining 17/27 (63.3%) items were rated by the PP in round 3, with 2/17 
items (11.7%) rated “essential” by the PP. PP proposed additional items for conclusion domain, which were rated by RPs in 
the fourth round. Poor consensus was observed for the format of reporting.
Conclusions This study provides a template for structured report of FLD that features essential items as agreed by expert 
thoracic radiologists and pulmonologists.
Keywords Structured report · Standardized report · Consensus · Lung fibrosis · High-resolution computed tomography
Abbreviation
DLD  Diffuse lung disease
FLD  Fibrosing lung disease
HRCT  High-resolution computed tomography
NSIP  Non-specific interstitial pneumonia
PPSs  Pulmonology panelists
RPs  Radiology panelists
UIP  Usual interstitial pneumonia
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Introduction
The radiology report is an essential part of the service that 
radiologists provide to both patients and referring physi-
cians, in any field of medicine. It records information for 
future use and it is part of the legal records for the episode 
of care [1]. The radiology report’s structure and content 
may vary according to several factors, including the clini-
cal inquiry, and the radiologist’s expertise and education.
Free text reporting is still the most common format in 
clinical radiology. However, free text clinical reports may 
heterogeneously render the core information (e.g., lan-
guage and cultural variability), making it difficult to com-
pare reports or find specific details [2, 3]. This is particu-
larly true for diffuse lung disease (DLD), which is often 
a challenging diagnosis and prone to variable description 
by high-resolution computed tomography (HRCT). Nota-
bly, there is no consensus on the relevant findings that 
should serve as core mandatory information to the refer-
ring physician. For instance, reporting enlarged lymph-
nodes might result misleading in patients with fibrosing 
lung disease (FLD) because these abnormalities frequently 
coexist without specific clinical implication.
A number of initiatives are being promoted by the major 
international societies of radiology to disseminate the use 
of structured reporting [4]. Potentially, the use of struc-
tured reporting may improve consistency in clinical radiol-
ogy [5]. It might reduce the rate of overlooking important 
findings as well as improve communication with referring 
physician. Several studies have explored pros and cons 
of the structured reporting in various settings. Some of 
them showed some benefit whereas others did not [2, 5–7]. 
However, it seems that most radiologists are encouraging 
and appreciating the use of structured reporting, especially 
in among subspecialist radiologists [8].
To our knowledge, there is no proposed structured 
reporting template for HRCT scans of subjects with 
DLD to guide radiologists in the systematic reporting in 
the framework of findings and synthesize a final clinical 
hypothesis. Following debates between expert pulmo-
nologists and chest radiologists at the Italian national 
meetings national meetings, respectively, from the Italian 
societies of respiratory medicine and the Italian society of 
medical radiology (SIRM), we hypothesized that a struc-
tured report might be particularly helpful for HRCT of 
patients with FLD.
Within the reference standard of multidisciplinary dis-
cussion, the radiology report remains the primary method 
of communication between radiologists and clinicians, 
particularly in non-referral centers. A simple stepwise 
approach can aid HRCT interpretation and is especially 
applicable to FLD, thus fitting structured reporting [9]. In 
fact, reducing the chance of omitting important findings 
(e.g., traction bronchiectasis or pulmonary emphysema), 
or supplying an interpretation of the radiological pattern, 
would be paramount to guide the referring physician in 
critical clinical decisions for patients with FLD.
This study was undertaken to enact critical shared dis-
cussion between chest radiologists and pulmonologists by 
means of multi-round consensus-building Delphi exercise, to 
develop a comprehensive focused structured reporting tem-
plate for HRCT of patients with FLD. The study objectives 
were to develop a list of HRCT criteria to describe FLD, to 
learn the most relevant parameters according to the point of 
view of pulmonologist, and to assess the agreement among 
experts on the proposed criteria.
Materials and methods
A six members writing committee proposed the HRCT cri-
teria and parameters—the Delphi items –to the panelists rat-
ing. The writing committee members had at least 10 years 
of experience and authored at least 10 studies in imaging of 
DLD and they did not participate in the following Delphi 
survey. The list of Delphi items was based on the evidence 
from the literature in FLD and the experience of each writ-
ing committee member.
Selection of the Delphi domains and items
A literature search was performed in Medline to identify 
publications relevant to the HRCT features of FLDs from 
2002 idiopathic interstitial pneumonia classification docu-
ment to January 2016 [10]. The full text of the selected stud-
ies was reviewed by two out of six members of the writing 
committee, who developed and shared the initial list of Del-
phi items with the other writing committee members via 
emails and teleconferences.
The structured report was divided into three domains 
according to the American College of Radiology handbook 
for residents: (a) initial considerations, (b) HRCT find-
ings, (c) Conclusions [11]. The Delphi items proposed by 
the writing committee are detailed in Table 1 according to 
domain belonging.
The domain “Initial considerations” included information 
needed for pre-test description of the clinical scenario and 
the quality of HRCT, as follows: available clinical indica-
tion, HRCT technique details (including technical differ-
ences potentially affecting the study comparison), and dis-
closure of motion artifacts.
The domain “HRCT findings” included the comparison of 
the HRCT findings with prior examinations, notably refer-
ring to extent and type of radiological findings (e.g., reticular 
opacities are increased in extent, traction bronchiectasis look 
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more severe, ground-glass opacity resolved, ground-glass 
opacity evolved towards overt reticulation, etc.). Further-
more, hierarchy of HRCT findings description was inves-
tigated with particular emphasis on the key components of 
the FLD, namely honeycombing, traction bronchiectasis, 
and signs of volume loss [9]. Furthermore, it was asked 
whether the description of the HRCT findings had to be 
concise or include also missing finding (e.g., not signs of 
honeycombing, not air trapping, etc.). It was also investi-
gated the relevance of disclosure of the confidence in diag-
nosing and differentiating honeycombing and traction bron-
chiectasis, which is a critical task even among expert chest 
radiologists [12].
Quantitative information was also among the items of 
“HRCT findings”, namely the relevance of reporting the 
extent of fibrosis and emphysema in the structured report. 
Table 1  List of Delphi items proposed by the writing committee for panelists survey
OP organizing pneumonia; PPFE Pleuro-Parenchymal Fibroelastosis
Initial considerations HRCT findings Conclusions
Available clinical indication Comparison of CT findings with prior scan, 
indicating change of each CT finding
CT pattern:
(1) DEFINITE UIP
(2) POSSIBLE UIP
(3) ACUTE COMPLICATIONS IN UIP
(4) NSIP
(5) NSIP-OP
(6) SARCOIDOSIS
(7) PPFE
CT protocol details Initial assessment of signs of lung fibrosis 
(honeycombing, traction bronchiectasis, signs 
of volume loss)
Proposal for the subsequent diagnostic test
Comparison with prior CT examinations Confidence on honeycombing against traction 
bronchiectasis
Indication for the timing of CT follow-up
Differences in CT technique with prior examina-
tions
Avoid description of absent findings
Motion artifacts Description of all CT findings
Description of the most relevant CT findings 
only (e.g., honeycombing, traction bronchiecta-
sis, signs of volume loss)
Disease distribution on both axial and cranio-
caudal planes
Differentiation between macro- and micro-cystic 
honeycombing
Description of the reticular opacities subtypes 
(e.g., intralobular or interlobular)
Emphysema subtype, including the so-called 
airspace enlargement with fibrosis
Quantitation of FLD extent as percentage of the 
lung volume
Quantitation of FLD extent according to three 
categories of severity
Quantitation of FLD extent for any disease OR 
for sarcoidosis and systemic sclerosis only
Quantitation of emphysema extent as percentage 
of the lung volume
Quantitation of emphysema extent according to 
three categories of severity
Report air trapping only when expiratory CT 
scan is performed
Suggest air trapping also on inspiratory CT scan
Report enlarged pulmonary artery for any dis-
ease OR for sarcoidosis and systemic sclerosis 
only
Report enlarged lymph-nodes
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Furthermore, the format of preferred visual scoring was pro-
posed as either continuous variable (e.g., percentage) or as 
category (e.g., mild, moderate, or severe). Of note, no cut-off 
values were a priori set to define the categories of disease 
extent (e.g., the category should be assigned according to 
radiologist subjective impression). In addition, it was investi-
gated whether extent should be provided for any FLD or only 
for individual disorders (e.g., sarcoidosis, systemic sclerosis) 
for which literature supported the prognostic value of such 
data at the time of the present study [13, 14]. Scientific refer-
ences were supplied to the panelists for informed review of 
the aforementioned items.
The domain “Conclusions” was meant to investigate the 
relevance of reporting the HRCT pattern (e.g., usual inter-
stitial pneumonia, UIP; non-specific interstitial pneumonia, 
NSIP, etc.), of proposing further diagnostic evaluation, and 
of indicating the timing for HRCT follow-up.
Selection of the study panelists
The  Italian Chest Imaging Subspecialty Society indi-
cated a list of 53 expert radiologists (38 males, age range 
30–72 years, median age 43 years, median years of experi-
ence in DLD 11 years), all active members of the Section of 
Thoracic Imaging of the SIRM, to participate in the Delphi 
survey (i.e., the radiology panelists—RPs). Selection criteria 
for RPs were as follows: (a) ≥ 5 years of experience in imag-
ing of DLD (as reported in the society database); (b) author-
ship of ≥ 3 articles on DLD in peer-reviewed journal. Like-
wise, 18 pulmonologists (13 males, age range 38-61 years, 
median age 53 years, median years of experience in DLD 
15) panelist (PP) were selected according to the following 
selection criteria: (a) ≥ 10 years of experience in DLD; 
(b) authorship of ≥ 10 articles on DLD in peer-reviewed 
journal. The selected RPs and PPs were contacted by email, 
informed about the aims and methodology of the study.
Overview of the Delphi exercise
The Delphi exercise was run by a biostatistician (with 5 
years of experience), through emails exchange.
First, RPs were asked to classify Delphi items into three 
categories, as follows: (a) “essential”; (b) “optional”; or (c) 
“not relevant” for the HRCT structured reporting. Items 
rated “essential” were further classified according to the for-
mat of reporting into “free text” or “outlined” (i.e., by a fixed 
check-list of descriptors or categories). A threshold of 80% 
“essential” rating by the RPs was set to retain items in the 
final structured report. Thereafter, items rated “essential” by 
less than 80% of the RPs were subsequently used to compile 
the Delphi item list for the PPs round. Again, a threshold of 
80% “essential” rating by the PPs was set to retain items in 
the definite structured report. Items rated “not relevant” were 
considered useless or misleading, therefore, excluded from 
the final structured report. Furthermore, all panelists were 
allowed to suggest additional items to be included in the 
item list for the subsequent round; this fostered the open dis-
cussion that this inter-specialty consultation was meant for.
In addition, PPs were also asked to judge the Delphi items 
that had been rated “essential” by the RPs, as follows: agree 
or disagree. The detailed sequence of steps of the Delphi 
survey is shown in Fig. 1.
Data analysis
Survey analysis was prospectively performed round by round 
[15]. In particular, the results of round 1 provided the con-
tent for sequential surveys. The cut-off value to retain an 
item within the exercise and eventually in the HRCT report-
ing model was ≥ 80% “essential” rating [16, 17]. Items 
with < 80% “essential” rating were iteratively rated at sub-
sequent rounds. Likewise, this cut-off value was also used 
to select the most appropriate format of reporting of each 
retained item (e.g., to be given as free text or to be outlined).
Results
Four Delphi rounds were performed to obtain the final struc-
tured report. A total of 42/53 (79.2%) invited radiologists 
agreed to participate as RPs. All of them completed the first 
round, 41 (97.6%) and 36 (85.7%) completed the second 
and the fourth round, respectively. A total of 12/18 (66.7%) 
pulmonologists agreed to participate as PPs and completed 
one Delphi round (i.e., the third round).
The result of each round is given in supplementary 
Tables 1–4 and summarized in Fig. 1. In round 1, 10/27 
(37.7%) Delphi items were rated “essential” by more than 
80% of RPs. In particular, total or nearly total agreement was 
reached for the following items: presence of prior HRCT 
scans for comparison, initial description of the variation of 
HRCT findings as compared to prior scans, and assessment 
of the disease distribution. No format option reached the 
cut-off of 80% and was re-rated in round 2 by the RPs. A 
number of panelists expressed no preference for the format 
of reporting as outlined in supplementary Tables.
In round 2, 17/27 (63%) items were re-rated by the RPs. A 
80% consensus was not reached for any of them. A consen-
sus greater than 80% was recorded upon the outline format 
for four out of 10 (40%) items that had been judged “essen-
tial” in round 1. Ten out of 42 (24%) RPs suggested to add 
an item for ancillary findings (e.g., pleural plaques, dilated 
esophagus, etc.), and report it as “free text”.
In round 3, PPs rated “essential” the extent of the visual 
scoring of both FLD (expressed as percentage lung volume 
involvement) and emphysema (expressed as categories). No 
La radiologia medica 
1 3
sufficient consensus was reached for the remaining 15 items 
that had not been rated “essential” by the RPs. Besides, the 
PPs unanimously agreed on both the set of 10 “essential” 
items chosen by the RPs. Furthermore, three (25%) PPs sug-
gested to expand on the conclusions domain by including 
a more detailed list of HRCT patterns and potential asso-
ciation or cause (e.g., unknown connective tissue disease, 
asbestosis, etc.) of FLD predictable from the HRCT findings. 
This was regarded as worth of rating by the radiologists writ-
ing committee that agreed upon a list of both HRCT patterns 
and associations of FLD.
In round 4, RPs chose between including only the HRCT 
patterns list or also suggesting any association or cause 
of the FLD in the structured report. There was substantial 
agreement upon suggesting the association or cause of the 
FLD too (85.7% “essential”).
The format option reached 80% consensus or higher for 
a few Delphi items (supplementary Tables 1–4). The format 
of each item included in the final template was chosen by the 
writing committee by taking into account the preferences of 
the majority of the RPs and PPs. Likewise, given the lack of 
consensus on the description of the CT findings other than 
CT features of FLD and the suggestion of reporting ancil-
lary findings in round 2, an item “other CT findings” (to be 
reported as “free text”) was included in the final structured 
report template.
By accounting for the rounds results, a final structured 
report template was finally developed by the writing com-
mittee, circulated and approved among all the participants 
(Fig. 2).
Discussion
We applied a rigorous consensus-building technique to iden-
tify the key items to be included in a structured report of 
FLD. In particular, it is the result of joint discussion between 
thoracic radiologists and pulmonologists. The iterative struc-
ture of the Delphi exercise showed a substantial agreement 
on the items progressively proposed for inclusion by each 
Fig. 1  Diagram summarizing the Delphi rounds results
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board of panelists, at subsequent rounds. The proposed tem-
plate for structured report of FLD comes as the first multi-
disciplinary example in the field.
The glossary of terms for thoracic imaging as well as 
the classification documents have both improved the inter-
pretation of the FLD [18–20]. However, there is no official 
reference for consistent reporting HRCT scan of subjects 
with FLD. This deficiency may have an impact on medi-
cal practice. Noteworthy, standardized structured reporting 
may reduce the risk of under-reporting important findings of 
FLD, especially in peripheral centers. Therefore, as for other 
specific topics, a structured report may well fit the FLD [21].
Ideally, the radiologic report should address both clinical 
and radiological needs, with a direct and easy format. On the 
clinical side, there is no official recommendation about the 
mandatory features of a radiological report, notably about 
suggesting association between HRCT pattern and cause of 
DLD. Furthermore, it is not clear whether the radiologic 
report should include proposals for the management. Both 
topics should be discussed according to the potential influ-
ence on clinical decision making, even in terms of poten-
tial medico-legal consequence [22]. This study was indeed 
driven by the need for practical interaction to improve the 
usefulness of the basic communicating system within mul-
tidisciplinary management of the patient, namely the radio-
logic report. Therefore, pulmonologists were involved in this 
study to integrate their needs in a shared structured report, 
and to rate the relevance of items selected by radiologists.
Interestingly, pulmonologists agreed on the choice of 
radiologists and suggested to include information on the 
extent of both FLD and emphysema, which were not rated 
“essential” by a sufficient proportion of radiologists. Fur-
thermore, pulmonologists proposed an additional item for 
the conclusions, namely the suggestion of possible cause or 
association of the FLD, which might be particularly useful to 
define the clinical choice for subsequent diagnostic work-up 
or management. For example, the compulsory radiological 
suggestion of a potential cause of FLD (e.g., asbestosis, con-
nective tissue disease, etc.) rather than the sole HRCT pat-
tern (e.g., UIP or NSIP), might encourage both radiologists 
to systematically look for important ancillary findings (e.g., 
pleural plaques, dilated esophagus, etc.) and pulmonologists 
to seek clinical investigation for the proposed association 
[23].
The Delphi exercise is one of the strengths of the present 
study. Indeed, it is a widely recognized method to investi-
gate consensus among experts. Noteworthy, the anonymity 
of panelists reduces the potential influence of strong opinion 
leaders on other participants and, thereby, the results of the 
survey [24]. The specific design of our Delphi survey was 
meant to first gather the opinion of radiologists, and then 
to investigate agreement of pulmonologists, especially on 
topics that are essential to the majority of expert radiolo-
gists. This logical sequence was particularly important for 
technical and medico-legal issues, which may be beyond the 
radiological “know how” of pulmonologists. Therefore, this 
approach granted main radiological address of the report 
with clinically significant adjustment from pulmonologists. 
The unanimous agreement of pulmonologists on items 
retained by radiologists suggests that all those items were 
clinically necessary, but allegedly they were not sufficient.
There are multiple formats for structured report, with no 
one being absolutely preferable over the other. They range 
from free text reporting with reference headers to predefined 
point-and-click options [25]. In our study, the panelists were 
Fig. 2  Final structured report template approved by all the study par-
ticipants
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asked to choose their preferred format for each item. There 
was poor consensus (threshold for consensus ≥ 80%) on the 
format for structured report. Both radiologists and pulmo-
nologists did not consider essential the reporting style of 
HRCT findings, particularly the avoidance of over-descrip-
tion and the disclosure of confidence on interpretation of key 
HRCT findings (e.g., honeycombing vs reticular abnormali-
ties superimposed to emphysema). Therefore, the format of 
each item included in the final template was chosen by the 
writing committee by taking into account the preferences of 
the majority of the RPs and PPs. We think that a combina-
tion of free text and outlined items may be helpful to either 
systematically disclose key unequivocal HRCT features 
(e.g., honeycombing) or describe the meaning of individual 
abnormalities that otherwise would be difficult to capture 
using a fixed check-list.
Further items included in the final structured report tem-
plate are worth of discussion. The clinical inquiry should be 
included in the first rows of the report to facilitate the struc-
tured answer to the specific question. Conversely, stating the 
absence of pertinent clinical history may help convey diag-
nostic uncertainties [25]. Moreover, the comparison with 
prior examinations might be prognostically relevant, thus it 
should be clearly addressed at each HRCT control. The pro-
posed structured report encourages the key discrimination 
between FLD and non-fibrotic DLD. Notably, the structured 
description of HRCT signs of FLD allows the list of poten-
tial diagnoses of DLD to be narrowed from over a hundred 
disorders to a handful of diseases [9].
Radiologists did not reach a consensus on the format of 
preferred visual scoring for emphysema extent. This was 
probably due to the current lack of clarity about the best 
method to be applied for that purpose, indeed the visual 
score is affected by quite an inter-observer variation. Fur-
thermore, the utility of semi-automatic software for emphy-
sema quantitation in routine activity has yet to be clarified, 
especially for emphysema in FLD [26]. Density masking is 
the current reference standard for emphysema quantification. 
This method is not suitable for quantification of patients 
with emphysema and FLD because it cannot discriminate 
between low density areas due to emphysema or associated 
with honeycomb cysts or traction bronchiectasis [27]. On 
the other hand, the total disease extent by categories would 
help stratifying patient prognosis, especially in sarcoidosis 
and systemic sclerosis. This was a topic of debate between 
radiologists and pulmonologists. In our survey, the radiolo-
gists did not reach a consensus on that [13, 14], whilst the 
pulmonologists preferred to include specific description 
of disease extent for any FLD as well as emphysema. This 
request from the pulmonologists is likely related to the need 
to get additional instruments to improve their interpretation 
of the patient clinico-functional profile.
The inclusion of air trapping in FLD seemed also con-
cerning for structure report. The predictive value of air 
trapping in FLD is still under evaluation, with no cut-off 
extent being recognized. Furthermore, air trapping may be 
independent from specific association with FLD (e.g., it has 
been reported in up to 32% of IPF cases) [28]. In a recent 
study, diffuse air trapping was the source of CT-pathologic 
discordance in 71.8% in IPF [29].
In the “Conclusions” domain, neither radiologists nor 
pulmonologists agreed upon suggesting specific diagnostic 
work-up because it was likely perceived as potentially mis-
leading, allegedly beyond the radiologists knowledge (e.g., 
radiologists have often limited information about the patient 
clinical condition and indeed cannot figure out what would 
be best for him).
This study has some limitations. First, the study panelists 
were from a single country, for this reason there was a rela-
tively small number of selected expert panelists. The par-
ticipation of opinion leaders from multiple countries would 
grant broader sharing and would increase the consistency 
of the structured report. We foster this National survey will 
prompt international survey to increase the number of par-
ticipants, which was likely not sufficiently large to address 
the study task. The Delphi items were evaluated according to 
the Italian terminology, nevertheless international scientific 
references were supplied for informed review. Second, the 
items were initially selected by the study writing committee, 
thus resulting in a modified Delphi exercise that could poten-
tially bias the structured report outline. Finally, this study 
did not aim to assess the impact of the structured report in 
the diagnosis and management of FLD. This issue will be 
discussed by forthcoming studies.
In conclusion, this study provides a template for struc-
tured report of FLD that features essential items as agreed 
by thoracic radiologists and their main speaker, the pulmo-
nologists. The multidisciplinary methodology strengthens 
the structured report utility for daily practice.
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